ID: ALA4800281

Max Phase: Preclinical

Molecular Formula: C42H47F3N8O9

Molecular Weight: 864.88

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CCOc1cc2nc(CCC(C)(C)C(=O)NCCOCCOCCNc3cccc4c3C(=O)N(C3CCC(=O)NC3=O)C4=O)n(C)c2cc1NC(=O)c1cccc(C(F)(F)F)n1

Standard InChI:  InChI=1S/C42H47F3N8O9/c1-5-62-31-23-27-30(22-28(31)50-36(55)26-10-7-11-32(48-26)42(43,44)45)52(4)33(49-27)14-15-41(2,3)40(59)47-17-19-61-21-20-60-18-16-46-25-9-6-8-24-35(25)39(58)53(38(24)57)29-12-13-34(54)51-37(29)56/h6-11,22-23,29,46H,5,12-21H2,1-4H3,(H,47,59)(H,50,55)(H,51,54,56)

Standard InChI Key:  NOBOQMWAZRMLTM-UHFFFAOYSA-N

Associated Targets(Human)

TMD8 415 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

OCI-Ly10 340 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Protein cereblon/IRAK4 80 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

OCI-LY19 76 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 864.88Molecular Weight (Monoisotopic): 864.3418AlogP: 4.26#Rotatable Bonds: 19
Polar Surface Area: 212.18Molecular Species: NEUTRALHBA: 13HBD: 4
#RO5 Violations: 2HBA (Lipinski): 17HBD (Lipinski): 4#RO5 Violations (Lipinski): 2
CX Acidic pKa: 11.59CX Basic pKa: 5.56CX LogP: 3.99CX LogD: 3.98
Aromatic Rings: 4Heavy Atoms: 62QED Weighted: 0.08Np Likeness Score: -1.15

References

1. Chen Y,Ning Y,Bai G,Tong L,Zhang T,Zhou J,Zhang H,Xie H,Ding J,Duan W.  (2021)  Design, Synthesis, and Biological Evaluation of IRAK4-Targeting PROTACs.,  12  (1.0): [PMID:33488968] [10.1021/acsmedchemlett.0c00474]

Source